Related Experiment Video
Updated: Aug 2, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Dieulafoy Lesion: Scope it Until You Find it
Alexander Kusnik1, Mostafa Reda Mostafa1, Rutwik Pradeep Sharma1
1Internal Medicine, Unity Hospital, Rochester Regional Health, Rochester, USA.
Abstract:
A Dieulafoy lesion is an important consideration every gastroenterologist and internal medicine physician has to make in cases of recurrent, unidentifiable, and hemodynamically compromising gastrointestinal (GI) bleeding. A Dieulafoy lesion is an aberrant vessel that does not reduce in caliber when it extends from the submucosa to the mucosa. Damage to this artery can result in severe, intermittent arterial bleeding from tiny, difficult-to-visualize vessel stumps. Furthermore, these catastrophic bleeding episodes frequently result in hemodynamic instability and the need for transfusion of multiple blood products. As the patients presenting with Dieulafoy lesions often have concomitant cardiac and renal disease, familiarity with this condition is relevant as these patients are at risk of transfusion-related injuries. This case is unique as the Dieulafoy lesion was not visualizable in a standard location despite multiple esophagogastroduodenoscopy (EGD) and CT angiography, illustrating the difficulty of accurately managing and diagnosing this condition.
Insights
Dieulafoy lesions are aberrant submucosal vessels causing severe gastrointestinal bleeding. Diagnosis can be challenging, even with advanced imaging, requiring physician awareness for effective management.
Area of Science:
- Gastroenterology
- Vascular Medicine
Background:
- Dieulafoy lesions are a critical consideration for recurrent, unexplained gastrointestinal (GI) bleeding.
- These lesions involve aberrant submucosal vessels that fail to constrict, leading to severe arterial hemorrhage.
Observation:
- Patients often present with hemodynamic instability and require multiple blood transfusions.
- Concomitant cardiac and renal conditions increase transfusion-related injury risks.
Findings:
- The case highlights diagnostic challenges, with the Dieulafoy lesion being non-visualizable in typical locations despite esophagogastroduodenoscopy (EGD) and CT angiography.
- This underscores the difficulty in accurately diagnosing and managing Dieulafoy lesions.
Implications:
- Increased physician awareness of Dieulafoy lesions is crucial for timely diagnosis and management.
- Understanding the risks in patients with comorbidities is vital for preventing transfusion-related complications.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Endoscopic Procedures V: ERCP
Patient...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...

